Skip to main content

Analysts Have Conflicting Sentiments on These Real Estate Companies: Compass (COMP) and Healthpeak Properties (DOC)

Tipranks - Tipranks - Fri Jan 9, 7:44AM CST

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Compass (COMP – Research Report) and Healthpeak Properties (DOC – Research Report).

Claim 70% Off TipRanks Premium

Compass (COMP)

In a report released today, Alec Brondolo from Wells Fargo maintained a Hold rating on Compass, with a price target of $8.00. The company’s shares closed last Wednesday at $11.84.

According to TipRanks.com, Brondolo is a 4-star analyst with an average return of 21.4% and a 63.9% success rate. Brondolo covers the NA sector, focusing on stocks such as Trade Desk, AppLovin, and Take-Two. ;'>

Compass has an analyst consensus of Strong Buy, with a price target consensus of $11.25, a -4.7% downside from current levels. In a report issued on December 31, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $11.00 price target.

See today’s best-performing stocks on TipRanks >>

Healthpeak Properties (DOC)

Evercore ISI analyst James Kammert maintained a Buy rating on Healthpeak Properties today and set a price target of $21.00. The company’s shares closed last Wednesday at $16.94.

According to TipRanks.com, Kammert is a 2-star analyst with an average return of 0.3% and a 41.5% success rate. Kammert covers the NA sector, focusing on stocks such as Essential Properties Realty, Four Corners Property, and Community Healthcare. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Healthpeak Properties with a $19.45 average price target, a 16.6% upside from current levels. In a report released yesterday, BMO Capital also reiterated a Buy rating on the stock with a $20.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).